glp-1 fatty liver The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis GLP-1 mimetics as a potential
Description
$350 to $550: both are viable

Sakata, K

doi: 10.36468/pharmaceutical-sciences.spl.428 39 UchinumaHIchijoMHarimaNTsuchiyaK

Diabetologia (2007) 50(8):175262
